radiotherapy

Showing 1 - 25 of 157

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
  • +4 more
Nov 16, 2023

Spinal Metastases, Spinal Tumor, Radiotherapy Trial in Shanghai (total en bloc spondylectomy)

Recruiting
  • Spinal Metastases
  • +4 more
  • total en bloc spondylectomy
  • Shanghai, Shanghai, China
    Shanghai Changzheng hospital
Nov 9, 2023

Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 2, 2023

Early Metastasis in Cervical Cancer Patients After Radiotherapy

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Oct 21, 2023

Breast Tumor, Radiotherapy, Breath Holding Trial in Ghent (Mental Exercises and Temporal Alteration)

Not yet recruiting
  • Breast Neoplasm
  • +3 more
  • Mental Exercises and Temporal Alteration
  • Ghent, Belgium
    University Hospital - Radiotherapy Department
Oct 20, 2023

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

Not yet recruiting
  • Metastatic Extracranial Malignant Solid Neoplasm
  • +3 more
  • Intestinal Low Dose Radiotherapy-1Gy
  • +3 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Oct 7, 2023

NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Yangzhou, Jiangsu, China
    People's hospital of northern jiangsu
Sep 26, 2023

Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)

Not yet recruiting
  • Advanced Non-Small Cell Squamous Lung Cancer
  • +2 more
  • CTV omitted or delineated
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 7, 2023

Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Recruiting
  • Radioembolization
  • +3 more
  • 18F-Fluoromisonidazole PET
  • Ankara, Turkey
    Ankara University
Sep 7, 2023

Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • CTV omitted or delineated
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 1, 2023

HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

Recruiting
  • HNSCC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Muscle Invasive Bladder Cancer, HER2 Expression, Radiotherapy Trial in Shanghai (Disitamab Vedotin and Toripalimab)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +4 more
  • Disitamab Vedotin and Toripalimab
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Jul 31, 2023

Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation

Recruiting
  • Radiotherapy
  • +3 more
  • Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
  • Munich, Germany
    Department of Radiation Oncology, Technical University of Munich
Aug 1, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

Radiotherapy, Prostate Cancer Trial in Lorient (Phone call)

Recruiting
  • Radiotherapy
  • Prostate Cancer
  • Phone call
  • Lorient, Bretagne, France
    Hôpital du Scorff
Jun 15, 2023

Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

Not yet recruiting
  • Advanced Diffuse Large B-Cell Lymphoma
  • +2 more
  • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
  • Radiotherapy beyond standard R-CHOP Chemotherapy
  • (no location specified)
May 24, 2023

Brain Metastases, Radiotherapy Trial in Heidelberg (Preoperative Radiotherapy, Intraoperative Radiation, Postoperative

Not yet recruiting
  • Brain Metastases
  • Radiotherapy
  • Preoperative Radiotherapy
  • +2 more
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
May 12, 2023

Lung Cancer, Radiotherapy, Stereotactic Body Radiotherapy Trial in Peking (SBRT)

Active, not recruiting
  • Lung Cancer
  • +3 more
  • SBRT
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Mar 26, 2023

Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between

Recruiting
  • Prostate Cancer
  • +5 more
  • grade and compare reported side effects between groups
  • Quebec, Canada
    CHUdeQuebec
Mar 14, 2023

Whether Five Factors Affect PFS in Locally Advanced Cervical

Completed
  • Locally Advanced Cervical Cancer
  • Radiotherapy
    • Chongqing, Chongqing, China
      Chongqing Cancer Hospital
    Mar 19, 2023

    Brain Metastases, Radiotherapy, EGFR Activating Mutation Trial in Guangdong (brain radiotherapy, Almonertinib)

    Recruiting
    • Brain Metastases
    • +2 more
    • Guangdong, Guangzhou, China
      Sun-Yat-Sen university
    Mar 13, 2023

    Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy Trial in Chongqing (Super-hyperfractionation Pulse Radiotherapy)

    Recruiting
    • Lung Cancer
    • +2 more
    • Super-hyperfractionation Pulse Radiotherapy
    • Chongqing, Chongqing, China
    • +1 more
    Feb 22, 2023